Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples

Rapid Communications in Mass Spectrometry

Volumn 24, Issue 13, 2010, Pages 1842-1850

  van den Broek, Irene ^a   Sparidans, Rolf W ^a   Schellens, Jan H M ^a,b   Beijnen, Jos H ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; BODY FLUIDS; DISEASES; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION;

ABSOLUTE QUANTIFICATION; HEAVY CHAIN; LC-MS-MS; LIQUID CHROMATOGRAPHY COUPLED TO TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ASSAYS; PEPTIDE FRAGMENTS; SENSITIVE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; SERUM MARKERS; SERUM SAMPLES; TRYPSIN INHIBITOR;

PEPTIDES;

EID: 77954262085     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.4588     Document Type: Article

References (20)

1. Nishimura H, Kakizaki I, Muta T, Sasaki N, Pu PX, Yamashita T, Nagasawa S. FEBS Lett. 1995; 357: 207.
2. Pu XP, Iwamoto A, Nishimura H, Nagasawa S. Biochim. Biophys. Acta 1994; 1208: 338.
3. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. J. Clin. Invest. 2006; 116: 271.
4. Fung ET, Yip TT, Lomas L, Wang Z, Yip C, Meng XY, Lin S, Zhang F, Zhang Z, Chan DW, Weinberger SR. Int. J. Cancer 2005; 115: 783.
5. Song J, Patel M, Rosenzweig CN, Chan-Li Y, Sokoll LJ, Fung ET, Choi-Miura NH, Goggins M, Chan DW, Zhang Z. Clin. Chem. 2006; 52: 1045.
6. Caputo E, Lombardi ML, Luongo V, Moharram R, Tornatore P, Pirozzi G, Guardiola J, Martin BM. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005; 819: 59.
7. Koomen JM, Li D, Xiao LC, Liu TC, Coombes KR, Abbruzzese J, Kobayashi R. J. Proteome Res. 2005; 4: 972.
8. Gast MC, Van Gils CH, Wessels LF, Harris N, Bonfrer JM, Rutgers EJ, Schellens JH, Beijnen JH. Oncol. Rep. 2009; 22:205.
9. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, Van Haaften-Day C, Hacker NF, de Bruijn HW, van der Zee AG, Jacobs IJ, Fung ET, Chan DW. Cancer Res. 2004; 64:5882.
10. van der Winden ACJ, van den Broek I, Gast MCW, Engwegen JYMN, Sparidans RW, van Dulken EJ, Depla ACTM, Cats A, Schellens JH, Peeters PHM, Beijnen JH, van Gils CH. J. Proteome Res. 2010; submitted.
11. Davis MT, Auger P, Spahr C, Patterson SD. Proteomics Clin. Appl. 2007; 1: 1545.
12. Diamandis EP. J. Natl. Cancer Inst. 2004; 96: 353.
13. van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008;872: 1.
14. Siskos AP, Katsila T, Balafas E, Kostomitsopolous N, Tamvakopoulos C. J. Prot. Res. 2009; 8: 3487.
15. Carr SA, Anderson L. Clin. Chem. 2008; 54: 1749.
16. van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Rapid Commun. Mass Spectrom. 2008; 22: 2915.
17. van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010; 878: 590.
18. Edelhoch H. Biochemistry 1967; 6: 1948.
19. Guidance for Industry: Bioanalytical Method Validation, U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research(CEDR), Center for Veterinary Medicine (CVM), BP, May 2001. Available: http://www.fda.gov/cder/guidance/4252fnl.htm.
20. National Centre for Biotechnology Information (NCBI), February 2010. Available: http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_002209.